Anita J. Brogan

Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States

Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski et al. · American Journal of Health-System Pharmacy · 2009 · 38 citations

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach

Anita J. Brogan, Sandra E. Talbird, Ashley E. Davis et al. · Human Vaccines & Immunotherapeutics · 2016 · 33 citations · Full text

B Lineage, Flu Vaccination, Vaccine Hesitancy +17

Dynamic transmission modelling to address infant pneumococcal conjugate vaccine schedule modifications in the UK

Matt Wasserman, A. O. Lucas, Dylan Jones et al. · Epidemiology and Infection · 2018 · 24 citations · Full text

Cost-Effectiveness Model for Neovascular Age-Related Macular Degeneration: Comparing Early and Late Treatment with Pegaptanib Sodium Based on Visual Acuity

Jonathan C. Javitt, Gergana Zlateva, Stephanie Earnshaw et al. · Value in Health · 2008 · 22 citations · Full text

Pegaptanib Sodium, Ocular Disease, Ophthalmology +5

Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C

Anita J. Brogan, Sandra E. Talbird, James R. Thompson et al. · PLoS ONE · 2014 · 21 citations · Full text